Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep-Oct;15(5):42-45.

Treatment for chest pain intercurrence after breast cancer surgery using Godoy's intermittent skin therapy

Affiliations

Treatment for chest pain intercurrence after breast cancer surgery using Godoy's intermittent skin therapy

Jose Maria Pereira de Godoy et al. Int J Health Sci (Qassim). 2021 Sep-Oct.

Abstract

Objective: Chest pain and swelling are routinely reported in women after breast cancer treatment and are often not valued by health professionals. In general, these patients suffer and without many effective solutions. The aim of the present study was to report the results of a novel technique for the treatment of chest pain related to breast cancer treatment.

Methods: A clinical trial was conducted involving 25 women with chest pain resulting from the treatment of breast cancer and submitted to treatment for lymphedema at the Godoy School in 2018. Godoy's intermittent dermal therapy was performed on the participants 2-4 h/day for 2 days until the occurrence of a significant improvement or complete resolution of pain (measured using the visual analog pain scale).

Results: All patients reported a significant reduction in pain in the first ½ h of treatment (P < 0.0001, Wilcoxon signed-rank test). Six of the 25 patients (24%) reported the absence of pain after treatment on the 1st day and all (100%) reported the absence of pain at the end of treatment on the 2nd day.

Conclusion: Chronic chest pain in patients having been submitted to treatment for breast cancer can be significantly reduced with Godoy's intermittent skin therapy, achieving standards of normality or near normality within only a few sessions.

Keywords: Breast cancer; Godoy’s intermittent skin therapy; chest pain; treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
One-dimensional pain intensity scale – VAS
Figure 2
Figure 2
Reduction in pain following intermittent skin therapy in treatment of chest lymphedema resulting from breast cancer treatment

References

    1. He L, Qu H, Wu Q, Song Y. Lymphedema in survivors of breast cancer. Oncol Lett. 2020;19:2085–96. - PMC - PubMed
    1. Forte AJ, Boczar D, Huayllani MT, Lu X, McLaughlin SA. Pharmacotherapy agents in lymphedema treatment:A systematic review. Cureus. 2019;11:e6300. - PMC - PubMed
    1. Symvoulakis EK, Anyfantakis DI, Lionis C. Primary lower limb lymphedema:A focus on its functional, social and emotional impact. Int J Med Sci. 2010;27:353–7. - PMC - PubMed
    1. Oluogun WA, Adedokun KA, Oyenike MA, Adeyeba OA. Histological classification, grading, staging, and prognostic indexing of female breast cancer in an African population:A 10-year retrospective study. Int J Health Sci. 2019;13:3–9. - PMC - PubMed
    1. Bruce J, Thornton AJ, Powell R, Johnston M, Wells M, Heys SD, et al. Psychological, surgical, and sociodemographic predictors of pain outcomes after breast cancer surgery:A population-based cohort study. Pain. 2014;155:232–43. - PubMed

LinkOut - more resources